Oculus Innovative Sciences Inc., a Petaluma, Calif., manufacturer of wound and skin care products for people, has moved into the veterinary channel by establishing an animal health division. The company in February released three over-the-counter medications for animals: MicrocynAH Wound & Skin Care liquid, MicrocynAH Wound & Skin Care Hydrogel and MicrocynAH Ophthalmic Gel. The products are available in the United States and Canada, and their European debut is planned for this summer. A veterinary-exclusive formulation may be launched by summer time, said Dan McFadden, Oculus’ vice president of animal health care. In addition, two MicrocynAH Farm and Ranch products for larger animals are expected to be introduced in March. MicrocynAH products contain a pH-neutral solution of hypochlorous acid and hypochlorite. “With over 45 patents, 10 FDA clearances and 10 CE marks, [the technology] has proven itself successful in over 30 human and animal clinical studies from around the globe,” McFadden said. “At the same time, our R&D team is … pioneering major advances in the key hypochlorous acid ingredient. … This includes significant improvements in product stability as well as in the actual chemistry, including the removal of bleach from the original liquid formulations.” SLA Brands, a manufacturer’s representative, is in charge of the marketing of MicrocynAH.
